Literature DB >> 28170271

Quantification and Qualitative Effects of Different PEGylations on Poly(butyl cyanoacrylate) Nanoparticles.

Andreas K O Åslund1, Einar Sulheim1,2, Sofie Snipstad1, Eva von Haartman3, Habib Baghirov1, Nichola Starr4, Mia Kvåle Løvmo1, Sylvie Lelú1, David Scurr4, Catharina de Lange Davies1, Ruth Schmid2, Ýrr Mørch2.   

Abstract

Protein adsorption on nanoparticles (NPs) used in nanomedicine leads to opsonization and activation of the complement system in blood, which substantially reduces the blood circulation time of NPs. The most commonly used method to avoid protein adsorption is to coat the NPs with polyethylene glycol, so-called PEGylation. Although PEGylation is of utmost importance for designing the in vivo behavior of the NP, there is still a considerable lack of methods for characterization and fundamental understanding related to the PEGylation of NPs. In this work we have studied four different poly(butyl cyanoacrylate) (PBCA) NPs, PEGylated with different types of PEG-based nonionic surfactants-Jeffamine M-2070, Brij L23, Kolliphor HS 15, Pluronic F68-or combinations thereof. We evaluated the PEGylation, both quantitatively by nuclear magnetic resonance (NMR), thermogravimetric analysis (TGA), and time-of-flight secondary ion mass spectrometry (ToF-SIMS) and qualitatively by studying ζ-potential, protein adsorption, diffusion, cellular interactions, and blood circulation half-life. We found that NMR and ToF-SIMS are complementary methods, while TGA is less suitable to quantitate PEG on polymeric NPs. It was found that longer PEG increases both blood circulation time and diffusion of NPs in collagen gels.

Entities:  

Keywords:  NMR; PACA; PEG; TGA; ToF-SIMS; circulation time; protein adsorption

Mesh:

Substances:

Year:  2017        PMID: 28170271     DOI: 10.1021/acs.molpharmaceut.6b01085

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  6 in total

1.  Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft.

Authors:  Abhilash D Pandya; Tore-Geir Iversen; Siver Moestue; Maria T Grinde; Ýrr Mørch; Sofie Snipstad; Andreas K O Åslund; Geir F Øy; Wanja Kildal; Olav Engebråten; Kirsten Sandvig; Tore Skotland; Gunhild M Mælandsmo
Journal:  Nanomaterials (Basel)       Date:  2021-04-28       Impact factor: 5.076

2.  Sonoporation Using Nanoparticle-Loaded Microbubbles Increases Cellular Uptake of Nanoparticles Compared to Co-Incubation of Nanoparticles and Microbubbles.

Authors:  Sofie Snipstad; Sigurd Hanstad; Astrid Bjørkøy; Ýrr Mørch; Catharina de Lange Davies
Journal:  Pharmaceutics       Date:  2021-04-30       Impact factor: 6.321

Review 3.  Analyzing the surface of functional nanomaterials-how to quantify the total and derivatizable number of functional groups and ligands.

Authors:  Daniel Geißler; Nithiya Nirmalananthan-Budau; Lena Scholtz; Isabella Tavernaro; Ute Resch-Genger
Journal:  Mikrochim Acta       Date:  2021-09-04       Impact factor: 5.833

4.  Subcellular detection of PEBCA particles in macrophages: combining darkfield microscopy, confocal Raman microscopy, and ToF-SIMS analysis.

Authors:  Antje Vennemann; Daniel Breitenstein; Elke Tallarek; Ýrr Mørch; Ruth Schmid; Martin Wiemann
Journal:  Drug Deliv Transl Res       Date:  2022-02-19       Impact factor: 5.671

5.  Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model.

Authors:  Habib Baghirov; Sofie Snipstad; Einar Sulheim; Sigrid Berg; Rune Hansen; Frits Thorsen; Yrr Mørch; Catharina de Lange Davies; Andreas K O Åslund
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

6.  Cytotoxicity of Poly(Alkyl Cyanoacrylate) Nanoparticles.

Authors:  Einar Sulheim; Tore-Geir Iversen; Vu To Nakstad; Geir Klinkenberg; Håvard Sletta; Ruth Schmid; Anne Rein Hatletveit; Ane Marit Wågbø; Anders Sundan; Tore Skotland; Kirsten Sandvig; Ýrr Mørch
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.